Page last updated: 2024-09-04

carbapenems and Hyperglycemia, Postprandial

carbapenems has been researched along with Hyperglycemia, Postprandial in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duan, J; Fu, C; Gong, R; Huang, X; Li, C; Liu, S; Liu, Y; Meng, X; Wu, A; Xiong, X; Zhang, Y; Zhou, P1

Other Studies

1 other study(ies) available for carbapenems and Hyperglycemia, Postprandial

ArticleYear
Risk factors and medical costs for healthcare-associated carbapenem-resistant Escherichia coli infection among hospitalized patients in a Chinese teaching hospital.
    BMC infectious diseases, 2017, 01-17, Volume: 17, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Case-Control Studies; Catheterization, Central Venous; Child; Child, Preschool; China; Cross Infection; Drug Costs; Drug Resistance, Bacterial; Escherichia coli Infections; Female; Health Care Costs; Hemoglobins; Hospitals, Teaching; Humans; Hyperglycemia; Incidence; Infant; Infant, Newborn; Length of Stay; Logistic Models; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Risk Factors; Tertiary Care Centers; Tracheostomy; Urologic Diseases; Young Adult

2017